SUBSCRIBE
SUBSCRIBE

Asia

Dentists In China Successfully Used A Robot To Perform Implant Surgery Without Human Intervention, Beihang University Reveals
September 22, 2017
 · 
1 min read
Wuhan’s XW Laboratories Inc. Closes $17.5 Million B Round To Develop CNS Drugs
September 21, 2017
 · 
1 min read
Deals
Zai Lab Completes $150 Million IPO; Stock Jumps 50% At Opening; Company Worth $1.4 Billion
September 20, 2017
 · 
1 min read
Alcobra Is A Net-Net That Could Sell Itself
September 20, 2017
 · 
1 min read
Fluorescence Microscopy On A Chip: No Lenses Required, American Institute of Physics Reveals
September 20, 2017
 · 
1 min read
Why Exiting the Generics Biz or a Break Up Could Save Troubled Teva
Deals
Why Exiting the Generics Biz or a Break Up Could Save Troubled Teva
September 20, 2017
 · 
2 min read
Biotech Beach
3 Of The Most Innovation-Forward Biotechs Right Now
September 19, 2017
 · 
1 min read
Tiny Electrically Pumped Micro-Lasers Epitaxially Grown On Industry Standard Silicon Substrates, Hong Kong University of Science and Technology Study
September 19, 2017
 · 
1 min read
Week In Review: Shanghai United Imaging Raises $500 Million In Series A; Zai Lab Will IPO Next Week
September 18, 2017
 · 
1 min read
Why Exiting the Generics Biz or a Break Up Could Save Troubled Teva
Deals
Debt-Ridden Teva Gets Ready to Unload Another Asset Worth $800 Million
September 14, 2017
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Innovent Announces the First Phase 3 Clinical Trial of Mazdutide in Chinese Adults with Overweight or Obesity Met the Primary and All Key Secondary Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA
January 8, 2024
 · 
9 min read
Astellas Provides Update on Zolbetuximab Biologics License Application in U.S.
January 8, 2024
 · 
4 min read
Drug Development
GC Cell’s Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform
January 8, 2024
 · 
4 min read
FDA
Techsomed’s BioTrace Solution Achieves De Novo Clearance from FDA as the First Ultrasound-Based Software for Tissue Response Prediction in Liver Tumor Ablation
January 8, 2024
 · 
3 min read
Akeso to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Share Its Corporate & Innovative Clinical Development Roadmap
January 8, 2024
 · 
8 min read
Business
Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma
January 8, 2024
 · 
5 min read
CollPlant’s CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
January 8, 2024
 · 
5 min read
Drug Development
Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
January 8, 2024
 · 
6 min read
Biotech Bay
Taiho Ventures Expands Investment Pool to $400 Million to Continue Quality Investments and Accelerate Open Innovation
January 8, 2024
 · 
2 min read
Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization
January 8, 2024
 · 
7 min read
Genetown
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China
January 8, 2024
 · 
7 min read
Drug Development
Biosion’s Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC)
January 8, 2024
 · 
4 min read
Business
Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine
January 8, 2024
 · 
3 min read
Drug Development
HighField Biopharmaceuticals HF1K16 Phase 1a Data Suggests the New Immuno-Oncology Drug is Safe, Well-Tolerated and Efficacious in Solid Tumors
January 8, 2024
 · 
2 min read
Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis
January 7, 2024
 · 
3 min read
Specialised Therapeutics signs exclusive agreement with Ascendis Pharma A/S for distribution and commercialisation of three endocrinology therapies in Australia and select South-East Asia countries
January 7, 2024
 · 
10 min read
FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara® (Ustekinumab)
January 5, 2024
 · 
2 min read
Deals
NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million
January 5, 2024
 · 
6 min read
Supplemental New Drug Application for Akeso’s Cadonilimab (PD-1/CTLA-4) Accepted by NMPA for First-line Treatment of Gastric Cancer
January 5, 2024
 · 
6 min read
Business
Praxis Precision Medicines Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China
January 5, 2024
 · 
5 min read
Load More